Clinical Features and Survival of Young Adults with Stage IV Gastric Cancer: a Japanese Population-Based Study.


Journal

Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627

Informations de publication

Date de publication:
Mar 2023
Historique:
accepted: 26 12 2021
medline: 15 5 2023
pubmed: 8 1 2022
entrez: 7 1 2022
Statut: ppublish

Résumé

With the aging of society, the mean age of patients with gastric cancer (GC) in Japan has increased. However, there are few documented outcomes for young patients with stage IV GC. We investigated the clinical characteristics and prognosis of such patients aged < 40 years using a dataset from an integrated population-based cohort study. We conducted this multicenter population-based cohort study to determine whether earlier onset of GC was a poor prognostic factor. We enrolled patients with metastatic GC aged < 40 years (young group) and those aged between 60 and 75 years (middle-aged group). Patients were histologically diagnosed as having gastric adenocarcinoma. We evaluated the overall survival (OS) of both groups and the hazard ratio (HR) for OS based on age. The adjusted HR with 95% confidence interval (CI) was evaluated using the Cox proportional hazards model after adjusting for confounding factors, including sex, histology, number of metastatic lesions, surgical resection, and chemotherapy. This study enrolled 555 patients. The patients were classified into the young (n = 20) and the middle-aged group (n = 535). The median OS durations were 5.7 and 8.8 months in the young and middle-aged groups, respectively (p = 0.029). The adjusted HR (95% CI) of the young group was 1.88 (1.17-3.04, p = 0.009). Age was an independent prognostic factor in patients with stage IV GC. Further studies investigating the genomic characteristics of GC and exploring more effective chemotherapeutic agents are required.

Identifiants

pubmed: 34994916
doi: 10.1007/s12029-021-00797-6
pii: 10.1007/s12029-021-00797-6
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-61

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Theuer CP, de Virgilio C, Keese G, et al. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg. 1996;172:473–7. https://doi.org/10.1016/S0002-9610(96)00223-1 .
doi: 10.1016/S0002-9610(96)00223-1 pubmed: 8942547
Song P, Wu L, Jiang B, Liu Z, Cao K, Guan W. Age-specific effects on the prognosis after surgery for gastric cancer: a SEER population-based analysis. Oncotarget. 2016;7:48614–48624. https://doi.org/10.18632/oncotarget.9548
Takatsu Y, Hiki N, Nunobe S, Ohashi M, Honda M, Yamaguchi T, Nakajima T, Sano T. Clinicopathological features of gastric cancer in young patients. Gastric Cancer. 2016;19:472–8. https://doi.org/10.1007/s10120-015-0484-1 .
doi: 10.1007/s10120-015-0484-1 pubmed: 25752270
Honda M, Wong SL, Healy MA, Nakajima T, Watanabe M, Fukuma S, Fukuhara S, Ayanian JZ. Long-term trends in primary sites of gastric adenocarcinoma in Japan and the United States. J Cancer. 2017;8:1935–42. https://doi.org/10.7150/jca.19174 .
doi: 10.7150/jca.19174 pubmed: 28819392 pmcid: 5559953
Shiota S, Murakawi K, Suzuki R, Fujioka T, Yamaoka Y. Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol. 2013;7:35–40. https://doi.org/10.1586/egh.12.67 .
doi: 10.1586/egh.12.67 pubmed: 23265147 pmcid: 3732492
Balakrishnan M, George R, Sharma A, Graham DY. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep. 2017;19:36. https://doi.org/10.1007/s11894-017-0575-8 .
doi: 10.1007/s11894-017-0575-8 pubmed: 28730504 pmcid: 6918953
Ławniczak M, Gawin A, Jaroszewicz-Heigelmann H, Rogoza-Mateja W, Białek A, Kulig J, Kaczmarczyk M, Starzyńska T. Analysis of clinicopathologic characteristics of gastric cancer in patients ≤40 and ≥40 years of age. Scand J Gastroenterol. 2020;55:62–6. https://doi.org/10.1080/00365521.2019.1699597 .
doi: 10.1080/00365521.2019.1699597 pubmed: 31852320
Santoro R, Carboni F, Lepiane P, Ettorre GM, Santoro E. Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg. 2007;94:737–42. https://doi.org/10.1002/bjs.5600 .
doi: 10.1002/bjs.5600 pubmed: 17330827
Wang Z, Xu J, Shi Z, Shen X, Luo T, Bi J, Nie M. Clinicopathologic characteristics and prognostic of gastric cancer in young patients. Scand J Gastroenterol. 2016;51:1043–9. https://doi.org/10.1080/00365521.2016.1180707 .
doi: 10.1080/00365521.2016.1180707 pubmed: 27181018
Zhang J, Gan L, Xu MD, Huang M, Zhang X, Gong Y, Wang X, Yu G, Guo W. The prognostic value of age in non-metastatic gastric cancer after gastrectomy: a retrospective study in the US and China. J Cancer. 2018;9:1188–99. https://doi.org/10.7150/jca.22085 .
doi: 10.7150/jca.22085 pubmed: 29675100 pmcid: 5907667
Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJH. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49. https://doi.org/10.1016/S1470-2045(10)70070-X .
doi: 10.1016/S1470-2045(10)70070-X pubmed: 20409751
Hsieh FJ, Wang YC, Hsu JT, Liu KH, Yeh CN. Clinicopathological features and prognostic factors of gastric cancer patients aged 40 years or younger. J Surg Oncol. 2012;105:304–9. https://doi.org/10.1002/jso.22084 .
doi: 10.1002/jso.22084 pubmed: 22116742
Ramos MFKP, Pereira MA, Sagae VMT, Mester M, Morrell ALG, Dias AR, Zilberstein B, Ribeiro Junior U, Cecconello I. Gastric cancer in young adults: a worse prognosis group? Rev Col Bras Cir. 2019;46: e20192256. https://doi.org/10.1590/0100-6991e-20192256 .
doi: 10.1590/0100-6991e-20192256 pubmed: 31576989
Lee JG, Kim SA, Eun CS, Han DS, Kim YS, Choi BY, Song KS, Kim HJ, Park CH. Impact of age on stage-specific mortality in patients with gastric cancer: a long-term prospective cohort study. PLoS ONE. 2019;14: e0220660. https://doi.org/10.1371/journal.pone.0220660 .
doi: 10.1371/journal.pone.0220660 pubmed: 31369631 pmcid: 6675285
Isobe T, Hashimoto K, Kizaki J, Miyagi M, Aoyagi K, Koufuji K, Shirouzu K. Characteristics and prognosis of gastric cancer in young patients. Oncol Rep. 2013;30:43–9. https://doi.org/10.3892/or.2013.2467 .
doi: 10.3892/or.2013.2467 pubmed: 23674196 pmcid: 3729235
Tavares A, Gandra A, Viveiros F, Cidade C, Maciel J. Analysis of clinicopathologic characteristics and prognosis of gastric cancer in young and older patients. Pathol Oncol Res. 2013;19:111–7. https://doi.org/10.1007/s12253-012-9530-z .
doi: 10.1007/s12253-012-9530-z pubmed: 22573278
Nakamura R, Saikawa Y, Takahashi T, Takeuchi H, Asanuma H, Yamada Y, Kitagawa Y. Retrospective analysis of prognostic outcome of gastric cancer in young patients. Int J Clin Oncol. 2011;16:328–34. https://doi.org/10.1007/s10147-011-0185-7 .
doi: 10.1007/s10147-011-0185-7 pubmed: 21301918
Li J. Gastric cancer in young adults: a different clinical entity from carcinogenesis to prognosis. Gastroenterol Res Pract. 2020;2020:9512707. https://doi.org/10.1155/2020/9512707 .
doi: 10.1155/2020/9512707 pubmed: 32190044 pmcid: 7071806
Rona KA, Schwameis K, Zehetner J, et al. Gastric cancer in the young: an advanced disease with poor prognostic features. J Surg Oncol. 2017;115:371–5. https://doi.org/10.1002/jso.24533 .
doi: 10.1002/jso.24533 pubmed: 28008624
Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245–51. https://doi.org/10.1016/0895-4356(94)90129-5 .
doi: 10.1016/0895-4356(94)90129-5 pubmed: 7722560
Zhao B, Mei D, Lv W, Lu H, Bao S, Lin J, Huang B. Clinicopathologic features, survival outcome, and prognostic factors in gastric cancer patients 18–40 years of age. J Adolesc Young Adult Oncol. 2020;9:514–21. https://doi.org/10.1089/jayao.2019.0162 .
doi: 10.1089/jayao.2019.0162 pubmed: 32069431
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9. https://doi.org/10.1038/nature13480 .
doi: 10.1038/nature13480
Sohn BH, Hwang JE, Jang HJ, et al. Clinical significance of four molecular subtypes of gastric cancer identified by the Cancer Genome Atlas project. Clin Cancer Res. 2017;23:4441–9. https://doi.org/10.1158/1078-0432.CCR-16-2211 .
doi: 10.1158/1078-0432.CCR-16-2211 pubmed: 28747339 pmcid: 5785562

Auteurs

Ryuya Yamamoto (R)

Department of Surgery, Southern Tohoku General Hospital, 7-115 Yatsuyamada, Koriyama City, Fukushima, 963-8563, Japan. dragon1119scorpion@gmail.com.

Michitaka Honda (M)

Department of Surgery, Southern Tohoku General Hospital, 7-115 Yatsuyamada, Koriyama City, Fukushima, 963-8563, Japan.
Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan.

Hidetaka Kawamura (H)

Department of Surgery, Southern Tohoku General Hospital, 7-115 Yatsuyamada, Koriyama City, Fukushima, 963-8563, Japan.
Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan.

Hiroshi Kobayashi (H)

Department of Surgery, Southern Tohoku General Hospital, 7-115 Yatsuyamada, Koriyama City, Fukushima, 963-8563, Japan.
Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan.

Koichi Takiguchi (K)

Department of Surgery, The Takeda Healthcare Foundation, Takeda General Hospital, Aizuwakamatsu, Japan.

Atsushi Muto (A)

Department of Surgery, Fukushima Rosai Hospital, Iwaki, Japan.

Shigeru Yamazaki (S)

Department of Surgery, Ohta Nishinouchi Hospital, Koriyama, Japan.

Yasushi Teranishi (Y)

Department of Surgery, Southern Tohoku General Hospital, 7-115 Yatsuyamada, Koriyama City, Fukushima, 963-8563, Japan.

Satoru Shiraso (S)

Department of Surgery, Iwaki City Medical Center, Iwaki, Japan.

Koji Kono (K)

Department of Gastrointestinal Tract Surgery, Fukushima Medical University, Fukushima, Japan.

Soshi Hori (S)

Department of Surgery, Southern Tohoku General Hospital, 7-115 Yatsuyamada, Koriyama City, Fukushima, 963-8563, Japan.
Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan.

Takahiro Kamiga (T)

Department of Surgery, Shirakawa Kosei General Hospital, Shirakawa, Japan.

Toshiyasu Iwao (T)

Department of Internal Medicine, Aidu Chuo Hospital, Aizuwakamatsu, Japan.

Naoyuki Yamashita (N)

Department of Surgery, Tsuboi Hospital, Koriyama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH